Programme

Introduction and methodology used, including panel members and Delphi panel members

Annalisa Berzigotti, Switzerland

General population

Emmanuel Tsochatzis, United Kingdom

Alcohol related liver disease

Maja Thiele, Denmark

Non-alcoholic fatty liver disease: diagnosis of steatosis and diagnosis of liver fibrosis

Laurent Castera, France

Non-alcoholic fatty liver disease: prognosis; patient selection and evaluation of treatment response in therapeutic trials

Jerome Boursier, France

Chronic hepatitis C post sustained virological response

Salvatore Petta, Italy

Cholestatic and autoimmune liver disease

Nora Cazzagon, Italy

Compensated advanced chronic liver disease and portal hypertension

Annalisa Berzigotti, Switzerland